GURUFOCUS.COM » STOCK LIST » USA » NYSE » Biohaven Pharmaceutical Holding Co Ltd (NYSE:BHVN) » Definitions » Days Inventory
Switch to:

Biohaven Pharmaceutical Holding Co Days Inventory

: 252.55 (As of Jun. 2022)
View and export this data going back to 2017. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). Biohaven Pharmaceutical Holding Co's Average Total Inventories for the three months ended in Jun. 2022 was $98.9 Mil. Biohaven Pharmaceutical Holding Co's Cost of Goods Sold for the three months ended in Jun. 2022 was $35.7 Mil. Hence, Biohaven Pharmaceutical Holding Co's Days Inventory for the three months ended in Jun. 2022 was 252.55.

The historical rank and industry rank for Biohaven Pharmaceutical Holding Co's Days Inventory or its related term are showing as below:

BHVN' s Days Inventory Range Over the Past 10 Years
Min: 239.26   Med: 527.69   Max: 816.12
Current: 246.61

During the past 7 years, Biohaven Pharmaceutical Holding Co's highest Days Inventory was 816.12. The lowest was 239.26. And the median was 527.69.

BHVN's Days Inventory is ranked worse than
65.05% of 598 companies
in the Biotechnology industry
Industry Median: 178.83 vs BHVN: 246.61

Biohaven Pharmaceutical Holding Co's Days Inventory declined from Jun. 2021 (322.04) to Jun. 2022 (252.55).

Inventory Turnover measures how fast the company turns over its inventory within a year. Biohaven Pharmaceutical Holding Co's Inventory Turnover for the three months ended in Jun. 2022 was 0.36.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Biohaven Pharmaceutical Holding Co's Inventory-to-Revenue for the three months ended in Jun. 2022 was 0.46.


Biohaven Pharmaceutical Holding Co Days Inventory Historical Data

The historical data trend for Biohaven Pharmaceutical Holding Co's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohaven Pharmaceutical Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Days Inventory
Premium Member Only Premium Member Only - - - 816.12 239.26

Biohaven Pharmaceutical Holding Co Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Days Inventory Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 322.04 248.43 197.32 297.72 252.55

Competitive Comparison

For the Biotechnology subindustry, Biohaven Pharmaceutical Holding Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Biohaven Pharmaceutical Holding Co Days Inventory Distribution

For the Biotechnology industry and Healthcare sector, Biohaven Pharmaceutical Holding Co's Days Inventory distribution charts can be found below:

* The bar in red indicates where Biohaven Pharmaceutical Holding Co's Days Inventory falls into.



Biohaven Pharmaceutical Holding Co Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Biohaven Pharmaceutical Holding Co's Days Inventory for the fiscal year that ended in Dec. 2021 is calculated as

Days Inventory (A: Dec. 2021 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2020 ) + Total Inventories (A: Dec. 2021 )) / count ) / Cost of Goods Sold (A: Dec. 2021 )*Days in Period
=( (39.563 + 80.608) / 2 ) / 91.664*365
=60.0855 / 91.664*365
=239.26

Biohaven Pharmaceutical Holding Co's Days Inventory for the quarter that ended in Jun. 2022 is calculated as:

Days Inventory (Q: Jun. 2022 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Mar. 2022 ) + Total Inventories (Q: Jun. 2022 )) / count ) / Cost of Goods Sold (Q: Jun. 2022 )*Days in Period
=( (91.281 + 106.561) / 2 ) / 35.741*365 / 4
=98.921 / 35.741*365 / 4
=252.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biohaven Pharmaceutical Holding Co  (NYSE:BHVN) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Biohaven Pharmaceutical Holding Co's Inventory Turnover for the three months ended in Jun. 2022 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Biohaven Pharmaceutical Holding Co's Inventory to Revenue for the three months ended in Jun. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Biohaven Pharmaceutical Holding Co Days Inventory Related Terms

Thank you for viewing the detailed overview of Biohaven Pharmaceutical Holding Co's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Biohaven Pharmaceutical Holding Co Business Description

Biohaven Pharmaceutical Holding Co logo
Traded in Other Exchanges
Address
C/o Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, CT, USA, 06510
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.
Executives
Antonijevic Irina director 215 CHURCH STREET NEW HAVEN CT 06510
Buten Matthew officer: Officer 215 CHURCH STREET NEW HAVEN CT 06510
Clark George C. officer: VP, Chief Accounting Officer 215 CHURCH STREET NEW HAVEN CT 06510
Mehta Kishan director 540 WEST 49TH STREET UNIT# PH1N NEW YORK NY 10019
Hugin Robert J director C/O THE MEDICINES CO 8 CAMPUS DR PARSIPPANY NJ 07054
Heffernan Michael Thomas director C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Stock Elyse officer: Chief Medical Officer 215 CHURCH STREET NEW HAVEN CT 06510
Jones William A Jr officer: CCO-Migraine & Common Disease NITROMED, INC. 125 SPRING STREET LEXINGTON MA 02421
Repella Robert director 1410 PARSONS LANE AMBLER PA 19002
Gregory Julia P director 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Gentile Kimberly officer: VP of Operations C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Childs John W director, 10 percent owner 111 HUNTINGTON AVENUE SUITE 2900 BOSTON MA 02199
Berman Robert officer: Chief Medical Officer C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Doogan Declan director C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Tilton John officer: Chief Commercial Officer C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510

Biohaven Pharmaceutical Holding Co Headlines

From GuruFocus

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)